Home › Burkitt-lymfoom › Colorado › Aurora
Burkitt-lymfoom klinische studies in Aurora, CO
10 studies voor Burkitt-lymfoom zoeken deelnemers op locaties in en rond Aurora (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekruterenFase 2
- Children's Hospital Colorado, Aurora
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruterenObservatieonderzoek
- Children's Hospital Colorado, Aurora
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekruterenFase 2
- Children's Hospital Colorado, Aurora
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RekruterenFase 1/2
- Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora
UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
RekruterenFase 1/2
- Children's Hospital Colorado, Aurora
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekruterenFase 2
- Children's Hospital Colorado, Aurora
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruterenFase 3
- Children's Hospital Colorado, Aurora
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
RekruterenFase 1
- Children's Hospital Colorado, Aurora
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
RekruterenFase 1/2
- University of Colorado - Aurora Cancer Center, Aurora
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
RekruterenFase 2
- Children's Hospital Colorado, Aurora
Burkitt-lymfoom studies in andere steden
- Houston, TX21 studies
- Milwaukee, WI16 studies
- Philadelphia, PA16 studies
- New York City, NY14 studies
- Chicago, IL14 studies
- Cincinnati, OH12 studies
- Atlanta, GA12 studies
- Seattle, WA11 studies
- Durham, NC10 studies
- Boston, MA10 studies
- Los Angeles, CA10 studies
- Kansas City, MO10 studies
Andere studies in Aurora
- Kanker (alle vormen)35 studies
- Colorectale kanker32 studies
- Niet-kleincellige longkanker30 studies
- Borstkanker27 studies
- Metastatische kanker25 studies
- Eierstokkanker25 studies
- Type 1-diabetes23 studies
- Obesitas21 studies
- Longkanker19 studies
- Prostaatkanker19 studies
- Hartfalen18 studies
- Melanoom18 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.